Center-Authored Papers

Filters: Author is Mielcarek, Marco  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
No Keywords
Mielcarek M, Kucera KA, Nash R, Torok-Storb B, McKenna HJ.  2007.  Identification and characterization of canine dendritic cells generated in vivo.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 13(11):1286-93. Abstract
Burroughs L, Mielcarek M, Little M-T, Bridger G, Macfarland R, Fricker S, Labrecque J, Sandmaier BM, Storb R.  2005.  Durable engraftment of AMD3100-mobilized autologous and allogeneic peripheral-blood mononuclear cells in a canine transplantation model.. Blood. 106(12):4002-8. Abstract
2008
Sorror ML, Leisenring WM, Mielcarek M, Baron F, Diaconescu R, Hogan WJ, Graves SS, Storb R.  2008.  Intensified postgrafting immunosuppression failed to assure long-term engraftment of dog leukocyte antigen-identical canine marrow grafts after 1 gray total body irradiation.. Transplantation. 85(7):1023-9. Abstract
Furlong T, Kiem H-P, Appelbaum FR, Carpenter PA, Deeg HJ, Doney K, Flowers MED, Mielcarek M, Nash RA, Storb R et al..  2008.  Sirolimus in combination with cyclosporine or tacrolimus plus methotrexate for prevention of graft-versus-host disease following hematopoietic cell transplantation from unrelated donors.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 14(5):531-7. Abstract
2009
Graves SS, Stone D, Loretz C, Peterson L, McCune JS, Mielcarek M, Storb R.  2009.  Establishment of long-term tolerance to SRBC in dogs by recombinant canine CTLA4-Ig.. Transplantation. 88(3):317-22. Abstract
Mielcarek M, Storer BE, Boeckh MJ, Carpenter PA, McDonald GB, Deeg HJ, Nash RA, Flowers MED, Doney K, Lee SJ et al..  2009.  Initial therapy of acute graft-versus-host disease with low-dose prednisone does not compromise patient outcomes.. Blood. 113(13):2888-94. Abstract
2010
Rotta M, Storer BE, Storb R, Martin PJ, Heimfeld S, Peffer A, Maloney DG, Deeg HJ, Sandmaier BM, Appelbaum FR et al..  2010.  Donor statin treatment protects against severe acute graft-versus-host disease after related allogeneic hematopoietic cell transplantation.. Blood. 115(6):1288-95. Abstract
Rotta M, Storer BE, Storb R, Martin PJ, Flowers MED, Vernon MS, Peffer A, Maloney DG, Deeg HJ, Sandmaier BM et al..  2010.  Impact of recipient statin treatment on graft-versus-host disease after allogeneic hematopoietic cell transplantation.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 16(10):1463-6. Abstract
2011
Sorror ML, Sandmaier BM, Storer BE, Franke GN, Laport GG, Chauncey TR, Agura E, Maziarz RT, Langston A, Hari P et al..  2011.  Long-term outcomes among older patients following nonmyeloablative conditioning and allogeneic hematopoietic cell transplantation for advanced hematologic malignancies.. JAMA : the journal of the American Medical Association. 306(17):1874-83. Abstract
Rezvani AR, Storer BE, Storb R, Mielcarek M, Maloney DG, Sandmaier BM, Martin PJ, McDonald GB.  2011.  Decreased Serum Albumin as a Biomarker for Severe Acute Graft-vs-Host Disease after Reduced-Intensity Allogeneic Hematopoietic Cell Transplantation.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 17(11):1594-1601. Abstract
Lee WS, Suzuki Y, Graves SS, Iwata M, Venkataraman GM, Mielcarek M, Peterson LJ, Ikehara S, Torok-Storb B, Storb R.  2011.  Canine bone marrow-derived mesenchymal stromal cells suppress alloreactive lymphocyte proliferation in vitro but fail to enhance engraftment in canine bone marrow transplantation.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 17(4):465-75. Abstract
Mielcarek M, Torok-Storb B, Storb R.  2011.  Pharmacological immunosuppression reduces but does not eliminate the need for total-body irradiation in nonmyeloablative conditioning regimens for hematopoietic cell transplantation.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 17(8):1255-60. Abstract
Inamoto Y, Flowers MED, Appelbaum FR, Carpenter PA, Deeg HJ, Furlong T, Kiem H-P, Mielcarek M, Nash RA, Storb R et al..  2011.  A retrospective comparison of tacrolimus versus cyclosporine with methotrexate for immunosuppression after allogeneic hematopoietic cell transplantation with mobilized blood cells.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 17(7):1088-92. Abstract
Mielcarek M, Storb R, Georges GE, Golubev L, Nikitine A, Hwang B, Nash RA, Torok-Storb B.  2011.  Mesenchymal stromal cells fail to prevent acute graft-versus-host disease and graft rejection after dog leukocyte antigen-haploidentical bone marrow transplantation.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 17(2):214-25. Abstract
Flowers MED, Inamoto Y, Carpenter PA, Lee SJ, Kiem H-P, Petersdorf EW, Pereira S, Nash RA, Mielcarek M, Fero ML et al..  2011.  Comparative analysis of risk factors for acute graft-versus-host disease and for chronic graft-versus-host disease according to National Institutes of Health consensus criteria.. Blood. 117(11):3214-9. Abstract
2012
Ram R, Storer BE, Mielcarek M, Sandmaier BM, Maloney DG, Martin PJ, Flowers MED, Chua BK, Rotta M, Storb R.  2012.  Association between Calcineurin Inhibitor Blood Concentrations and Outcomes after Allogeneic Hematopoietic Cell Transplantation.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 18(3):414-422. Abstract
Mielcarek M, Storer B, Martin PJ, Forman SJ, Negrin RS, Flowers ME, Inamoto Y, Chauncey TR, Storb R, Appelbaum FR et al..  2012.  Long-term outcomes after transplantation of HLA-identical related G-CSF-mobilized peripheral blood mononuclear cells versus bone marrow.. Blood. 119(11):2675-2678. Abstract
2013
Sato M, Storb R, Loretz C, Stone D, Mielcarek M, Sale GE, Rezvani AR, Graves SS.  2013.  Inducible costimulator (ICOS) up-regulation on activated T cells in chronic graft-versus-host disease after dog leukocyte antigen-nonidentical hematopoietic cell transplantation: a potential therapeutic target.. Transplantation. 96(1):34-41. Abstract
Storb R, Gyurkocza B, Storer BE, Sorror ML, Blume K, Niederwieser D, Chauncey TR, Pulsipher MA, Petersen FB, Sahebi F et al..  2013.  Graft-versus-host disease and graft-versus-tumor effects after allogeneic hematopoietic cell transplantation.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 31(12):1530-8. Abstract
Storb R, Gyurkocza B, Storer BE, Maloney DG, Sorror ML, Mielcarek M, Martin PJ, Sandmaier BM.  2013.  Allogeneic Hematopoietic Cell Transplantation Following Minimal Intensity Conditioning: Predicting Acute Graft-versus-Host Disease and Graft-versus-Tumor Effects.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 19(5):792-8. Abstract
Green ML, Leisenring WM, Xie H, Walter RB, Mielcarek M, Sandmaier BM, Riddell SR, Boeckh MJ.  2013.  CMV reactivation after allogeneic HCT and relapse risk: evidence for early protection in acute myeloid leukemia.. Blood. 122(7):1316-1324. Abstract
Inamoto Y, Martin PJ, Storer BE, Mielcarek M, Storb RF, Carpenter PA.  2014.  Response endpoints and failure-free survival after initial treatment for acute graft-versus-host disease.. Haematologica. 99(2):385-91. Abstract
2014
Inamoto Y, Martin PJ, Storer BE, Mielcarek M, Storb RF, Carpenter PA.  2014.  Response endpoints and failure-free survival after initial treatment for acute graft-versus-host disease.. Haematologica. 99(2):385-91. Abstract
Castilla-Llorente C, Martin PJ, McDonald GB, Storer BE, Appelbaum FR, Deeg HJ, Mielcarek M, Shulman H, Storb R, Nash RA.  2014.  Prognostic factors and outcomes of severe gastrointestinal GVHD after allogeneic hematopoietic cell transplantation.. Bone marrow transplantation. 49(7):966-71. Abstract
Mielcarek M, Kirkorian AY, Hackman RC, Price J, Storer BE, Wood BL, Leboeuf M, Bogunovic M, Storb R, Inamoto Y et al..  2014.  Langerhans Cell Homeostasis and Turnover After Nonmyeloablative and Myeloablative Allogeneic Hematopoietic Cell Transplantation.. Transplantation. 98(5):563-8. Abstract